MK0634

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK0634, covering 2015-12-17 to 2015-12-17. Get the full timeline:

Most recent: Clinical Trial Update: A Placebo-Controlled Study of MK0634 in Patients With Overactive Bladder (0634-007) [Phase 2]